Number of qualified patients: CDEC talked over the uncertainty in the quantity of clients with moderately critical to significant hemophilia B in Canada qualified for etranacogene dezaparvovec. Clinical specialists consulted by CADTH indicated that some individuals who are classified as owning delicate or average ailment can have a severe bleeding https://hemgenix41604.blogocial.com/everything-about-hemgenix-71528773